Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „sofosbuvir“
Suchtreffer
Begriffe & Kennungen
Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · similar results. 2 The predominant circulating metabolite of sofosbuvir. 3 Study conducted with additional vox
Eintrag öffnenEpclusa · 4.5 · (Increase in gastric pH) Famotidine Sofosbuvir ↓ ↓ (40 mg single dose)/ 0.77 0.80 sofosbuvir/ velpatasvir (0.6
Eintrag öffnenEpclusa · 4.5 · (Increase in gastric pH) Omeprazole Sofosbuvir ↓ ↔ (20 mg once daily)/ 0.79 sofosbuvir/ velpatasvir (0.68, (40
Eintrag öffnenEpclusa · 4.5 · (Increase in gastric pH) Omeprazole Sofosbuvir ↓ ↔ (20 mg once daily)/ 0.79 sofosbuvir/ velpatasvir (0.68, (40
Eintrag öffnenEpclusa · 4.5 · (Increase in gastric pH) Proton pump inhibitors Omeprazole Sofosbuvir ↓ ↓ Co-administration with proton (20 mg
Eintrag öffnenEpclusa · 4.5 · (Increase in gastric pH) Proton pump inhibitors Omeprazole Sofosbuvir ↓ ↓ Co-administration with proton (20 mg
Eintrag öffnenEpclusa · 4.5 · (Induction of P-gp and Observed: ↓ ↓ CYPs) Sofosbuvir 0.64 0.76 (0.53, (0.63, 0.77) 0.91)
Eintrag öffnenEpclusa · 4.5 · (Induction of P-gp and Observed: ↓ ↓ CYPs) Sofosbuvir 0.64 0.76 (0.53, (0.63, 0.77) 0.91) Rifapentine Interact
Eintrag öffnenEpclusa · 4.5 · (Induction of P-gp and Observed: ↓0.52 ↓ 0.52 CYPs) Sofosbuvir (0.43, (0.46, 0.62) 0.59)
Eintrag öffnenEpclusa · 4.5 · (Induction of P-gp and Observed: ↓0.52 ↓ 0.52 CYPs) Sofosbuvir (0.43, (0.46, 0.62) 0.59)
Eintrag öffnenEpclusa · 4.5 · As Epclusa contains sofosbuvir and velpatasvir, any interactions that have been identified with these active s
Eintrag öffnenEpclusa · 4.5 · As Epclusa contains sofosbuvir and velpatasvir, any interactions that have been identified with these active s
Eintrag öffnenEpclusa · 4.5 · Sofosbuvir and velpatasvir are substrates of drug transporters P-gp and BCRP. Velpatasvir is also a substrate
Eintrag öffnenEpclusa · 4.5 · Sofosbuvir and velpatasvir are substrates of drug transporters P-gp and BCRP. Velpatasvir is also a substrate
Eintrag öffnenEpclusa · 4.8 · Cardiac arrhythmias Cases of severe bradycardia and heart block have been observed when sofosbuvir-containing
Eintrag öffnenEpclusa · 4.8 · Cardiac arrhythmias Cases of severe bradycardia and heart block have been observed when sofosbuvir-containing
Eintrag öffnenEviplera · 4.5 · Rilpivirine: AUC: ↔ Cmax: ↔ Cmin: ↔ Sofosbuvir/Tenofovir disoproxil Interaction not studied. Ribavirin/Tenofov
Eintrag öffnenEviplera · 4.5 · Tenofovir: AUC: ↑ Cmax: ↑ Cmin: ↑ Sofosbuvir/Emtricitabine Interaction not studied. No dose adjustment is requ
Eintrag öffnenEviplera · 4.5 · Tenofovir: AUC: ↓ 10% C12h: ↓ 13% Cmax: ↓ 23% Other antiviral agents Ledipasvir/Sofosbuvir Ledipasvir: No dose
Eintrag öffnenGenvoya · 4.5 · Sofosbuvir metabolite GS-331007: AUC: ↑ 48% Cmin: ↑ 66% Cmax: ↔
Eintrag öffnen